[1]
J. C. Nickel, K.-L. Kelly, A. Griffin, D. S. Elterman, J. Clark-Pereira, and R. C. Doiron, “MV140 sublingual vaccine reduces recurrent urinary tract infection in women: Results from the first North American clinical experience study”, CUAJ, vol. 18, no. 2, pp. 25–31, Oct. 2023.